Table 1.

Patient characteristics for the subset that was selected for double immunofluorescence experiments; all of age 31–40 years

Patient	Child birth(s)	Family history of breast cancer	BRCA1/2 mutation	Pathology diagnosis
17	No	No	No	IDC
75	No	No	No	IDC
91	No	No	No	Benign
62	Yes	No	No	Benign
97	Yes	No	No	IDC
59	Yes	No	No	Benign
89	Yes	Yes	No	IDC
78	No	Yes	No	IDC
30	No	Yes	No	IDC
83	Yes	Yes	No	IDC
46	Yes	Yes	BRCA1	DCIS
99	Yes	Yes	BRCA1	IDC
103	Yes	Yes	BRCA1	IDC
116	No	Yes	BRCA2	IDC
37	Yes	Yes	BRCA2	Benign
126	Yes	Yes	BRCA2	Benign

Abbreviations: IDC invasive ductal carcinoma DCIS ductal carcinoma in situ